A Real-life Observational Study in Severe Eosinophilic Asthma Adult Participant Treated With Benralizumab in Italy

Study to Evaluate the Effect of Benralizumab on Allergen-Induced Inflammation in Mild, Atopic Asthmatics

NCT02821416 ·Status: COMPLETED ·Phase: PHASE3

Benralizumab Airway Remodeling Study in Severe Eosinophilic Asthmatics

NCT03953300 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4

Evaluating the Effect of Benralizumab in Severe, Poorly-controlled Eosinophilic Asthma Using Inhaled Hyperpolarized 129-Xenon MRI

NCT03733535 ·Status: ACTIVE_NOT_RECRUITING ·Phase: NA

Study to Assess Functionality, Reliability, and Performance of a Pre-filled Syringe With Benralizumab Administered at Home

NCT02417961 ·Status: COMPLETED ·Phase: PHASE3

BenRalizumab Effect on Airway Remodeling in Severe asTHma

NCT06288516 ·Status: RECRUITING ·Phase: PHASE4

Real World Study With Benralizumab in Severe Asthma in Switzerland

NCT03907137 ·Status: COMPLETED

Characterisation of Patients With Severe Asthma in Primary and Secondary Care Settings in Europe Reported to be Eligible for Biological Therapy

NCT03629782 ·Status: COMPLETED

A Non-interventional, Prospective Study With Benralizumab

NCT06422078 ·Status: RECRUITING

A Study to Evaluate the Onset of Effect and Time Course of Change in Lung Function With Benralizumab in Severe, Uncontrolled Asthma Patients With Eosinophilic Inflammation

NCT02869438 ·Status: COMPLETED ·Phase: PHASE3

Study to Evaluate the Efficacy and Safety of Benralizumab in Adult Patients With Mild to Moderate Persistent Asthma

NCT02322775 ·Status: COMPLETED ·Phase: PHASE3

Benralizumab in Patients With Inadequate Response to Anti-IL5 Monoclonal Antibody Therapies

NCT03470311 ·Status: COMPLETED ·Phase: PHASE3

Impact of Benralizumab Treatment on Circulating Dendritic Cells in Patients With Eosinophilic Asthma

NCT03652376 ·Status: UNKNOWN ·Phase: PHASE4

Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain

NCT04126499 ·Status: COMPLETED

STEP: Phase IIIb Study of Benralizumab to Step-down Maintenance Therapy in Patients With Severe Eosinophilic Asthma

NCT06465485 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3

PK/PD and Long Term Safety Study of Benralizumab in Children With Severe Eosinophilic Asthma

NCT04305405 ·Status: COMPLETED ·Phase: PHASE3

A Study to Assess the Reduction of Daily Maintenance ICS/LABA Treatment Towards Anti-Inflammatory Reliever Treatment in Patients With Severe Eosinophilic Asthma Treated With Benralizumab

NCT04159519 ·Status: COMPLETED ·Phase: PHASE4

Patient-Reported OUTcomes of Benralizumab in Real-World Use in Severe EosiNophilic Asthma Patients

NCT05603845 ·Status: COMPLETED

Study in Portuguese Hospitals to Describe Patient Characteristics, Treatment Patterns and Outcomes

NCT07159295 ·Status: COMPLETED

A Multicentre, Randomised, Double-blind, Parallel Group, Placebo-controlled, Time-to-first Asthma Exacerbation Phase III Efficacy and Safety Study of Benralizumab in Paediatric Patients With Severe Eosinophilic Asthma (DOMINICA)

NCT05692180 ·Status: RECRUITING ·Phase: PHASE3

Benralizumab Exacerbation Study

NCT04102800 ·Status: COMPLETED ·Phase: PHASE4

This is a Non-interventional, Study to Assess Demographic Characteristics and Patient Reported Outcomes in China Patients With SEA Treated With Benralizumab

NCT06862206 ·Status: RECRUITING

Observational Retrospective Study on Clinical Outcomes of Patients Receiving Benralizumab in Spain.

NCT04648839 ·Status: COMPLETED

A Study of GSK3511294 (Depemokimab) Compared With Mepolizumab or Benralizumab in Participants With Severe Asthma With an Eosinophilic Phenotype

NCT04718389 ·Status: COMPLETED ·Phase: PHASE3

Patients With Severe Eosinophilic Asthma Treated With Benralizumab

NCT05078281 ·Status: UNKNOWN

A Study to Assess the Effect of Dexpramipexole in Adolescents and Adults With Severe Eosinophilic Asthma.

NCT05763121 ·Status: TERMINATED ·Phase: PHASE3